Newsfiscal.ai
Co-Diagnostics Joint Venture CoSara Submits Tuberculosis Test for Regulatory Clearance in India
· Published
Article summary
Co-Diagnostics, Inc. announced that its Indian joint venture, CoSara Diagnostics, has completed a clinical performance study for its PCR Mycobacterium tuberculosis test and submitted it to the CDSCO for regulatory approval.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…